Abstract-The applications of targeted drugs in treating cancers have significantly improved the survival rates of patients. However, in the clinical practice, targeted drugs are commonly combined with chemotherapy drugs, causing that the exact contribution of targeted drugs to the clinical outcome is difficult to evaluate. Quantitatively investigating the effects of targeted drugs on chemotherapy drugs on cancer cells is useful for us to understand drug actions and design better drugs. The advent of atomic force microscopy (AFM) provides a powerful tool for probing the nanoscale physiological activities of single live cells. In this paper, the detailed changes in cell morphology and mechanical properties were quantified on single lymphoma cells during the actions of rituximab (a monoclonal antibody targeted drug) and two chemotherapy drugs (cisplatin and cytarabine) by AFM. AFM imaging revealed the distinct changes of cellular ultramicrostructures induced by the drugs. The changes of cellular mechanical properties after the drug stimulations were measured by AFM indenting. The statistical histograms of cellular surface roughness and mechanical properties quantitatively showed that rituximab could remarkably strengthen the killing effects of chemotherapy drugs. The study offers a new way to quantify the synergistic interactions between targeted drugs and chemotherapy drugs at the nanoscale, which will have potential impacts on predicting the efficacies of drug combinations before clinical treatments.
I. INTRODUCTION

I
N recent years, antibody-based immunotherapy is increasingly becoming an important part of cancer treatment [1] , [2] . Rituximab (Rtx), approved by U.S. Food and Drug Administration in 1997, was the first therapeutic antibody for the treatment of a human cancer-B-cell non-Hodgkin lymphoma [3] . The target of Rtx is the CD20 molecule which is expressed on the surface of lymphoma cells. In vitro studies have shown that the binding of Rtx to CD20 can deplete the tumor cell via several mechanisms, e.g., directly inducing the cellular apoptosis, recruiting immune cells (e.g., macrophage, NK cell) to attack the tumor cell, and triggering the signaling pathway of complementmediated cytotoxicity [4] . So far the in vivo mechanisms of Rtx are still unclear and the role of each mechanism remains disputed [5] , but the efficacy of Rtx in lymphoma treatment is without doubt. The clinical trials had demonstrated that the addition of Rtx to conventional chemotherapy led to an impressive improvement of response rates and survival outcomes in patients with high-grade lymphoma (such as diffuse large B-cell lymphoma) [6] or with indolent lymphoma (such as follicular lymphoma) [7] . Currently, the combination of Rtx and chemotherapy has become the standard therapy for most B-cell lymphomas [8] . Despite the unprecedented success of Rtx, a proportion of patients with B-cell non-Hodgkin lymphomas develop resistance to Rtx, and, thus, the current challenge lies in providing effective therapies for these patients [9] . Several mechanisms have been postulated to interpret the resistance of Rtx, e.g., downregulation or loss of CD20, blocking the activation of complement, and impaired antibody-dependent cellular cytotoxicity [10] , [11] . However, due to the fact that Rtx is commonly combined with chemotherapy drugs, in the practice, the exact contribution of these mechanisms to the clinical phenomenon of Rtx resistance is difficult to evaluate [11] . Many novel anti-CD20 antibodies have been developed and entered the clinic (e.g., ofatumumab, tositumomab, and obinutuzumab), but to date none of the newer anti-CD20 antibodies have been shown to be clinically more effective than Rtx in a direct comparison [8] . In order to improve the potency of anti-CD20 antibodies beyond that achieved with Rtx, we should have a thorough understanding of Rtx-induced cellular physiological activities taking place in clinical environments. Viewed from this aspect, investigating the synergistic interactions between Rtx and chemotherapy drugs is useful for us to understand the real actions of Rtx and then design better drugs, which may have clinical impact on the treatment of lymphomas.
Traditional studies that investigated the cellular behaviors were commonly based on optical microscopy or scanning electron microscopy (SEM). Optical microscopy cannot reveal the nanoscale situations due to the limit of 200-nm spatial resolution, while SEM cannot observe living cells. Though environmental SEM can observe the sample containing certain 0018-9294 © 2015 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
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moisture, currently its spatial resolution is low and is still unable to image living cells in physiological conditions [12] . In recent years, the applications of atomic force microscopy (AFM) in observing nanoscale cellular activities have contributed much to the field of cell biology [13] , [14] . AFM has nanometer spatial resolution and can work in liquids, meaning that it can directly observe the dynamics of nanostructures on living cells (e.g., vesicles [15] , cytoskeletons [16] ). Besides visualizing surface morphology, via indenting techniques AFM can obtain multiple parameters that reflect the physiological properties of cells, such as mechanical properties, adhesion forces, and energy dissipation [17] . Hence, AFM is an adequate tool for probing the nanoscale cellular behaviors. So far to our knowledge, quantitatively investigate the interactions between targeted drugs and chemotherapy drugs on single cells at the nanoscale have not been reported. In this paper, AFM was applied to quantitatively investigate the effects of Rtx on two chemotherapy drugs (cisplatin and cytarabine) on single lymphoma cells by visualizing and measuring the changes of cellular ultramicrostructures and mechanical properties after the stimulations of different drug combinations (single agents and combined agents).
II. MATERIALS AND METHODS
A. Cell and Agents
Human Burkitt's lymphoma (a type of B-cell lymphoma) Raji cell line was used in this study. Raji cells were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). Rtx (10 mg/mL), cisplatin (1 mg/mL), and cytarabine (20 mg/mL) were obtained from the Affiliated Hospital of Military Medical Academy of Sciences (Beijing, China). Trypan blue staining solution was purchased from Solarbio Science & Technology Co. Ltd (Beijing, China). Raji cells were cultured in flasks in RPMI-1640 medium containing 10% fetal bovine serum and 1% penicillin-streptomycin solution at 37°C (5%CO 2 ).
B. Optical Microscopy
Cells were cultured in 24-well sterile tissue culture plates for trypan blue staining and cell counting experiments. The experimental procedure contained three steps: 1) 1-mL Raji cell suspensions were added to the wells and then agents (single agents or combined agents) with different concentrations were added to the wells. Cells were then incubated at 37°C (5%CO 2 ). 2) After the incubation (12, 24, 48 h), 100-μL trypan blue solutions (0.4%) were added to the wells and incubated for 3 min at room temperature. 3) After the incubation, cells from the wells were added to the haemocytometer. Then, the haemocytometer was placed on the sample stage of an inverted microscope (Ti, Nikon, Tokyo, Japan). The numbers of dead cells and live cells were obtained via counting the cells located in the four grids of the haemoctometer according to the trypan blue staining of the cells. Trypan blue molecules can penetrate the membrane of dead cells and then stained the cells. Under the microscope, dead cells were blue while live cells were colorless and bright (as shown in Fig. 1 ). The cell viability was calculated according (1)
C. AFM Imaging
AFM experiments were carried out with a Bioscope Catalyst AFM (Bruker, Santa Barbara, CA, USA) which was set on an inverted microscope (Ti, Nikon, Tokyo, Japan), as shown in Fig. 2(a) . The type of the probe was MLCT (Bruker, Santa Barbara, CA, USA), and the cantilever with nominal spring constant 0.01 N/m was used [18] . For AFM imaging, Raji cells (treated by different drug combinations in cell incubator) from the 24-well culture plates were dropped onto the glass slides which were coated by poly-L-lysine. The role of poly-L-lysine was attaching cells onto the substrate via electrostatic adsorption [12] . Raji cells on the glass slides were then chemically fixed by 4% paraformaldehyde for 30 min. AFM images of Raji cells were acquired in phosphate buffered saline. Under the guidance of optical microscopy, AFM tip was moved to the cells and then AFM images of the cells were obtained at contact mode. The scan line was 256 and the sampling point for each scan line was 256. The scan rate was 0.5 Hz. Both the height image and deflection image were recorded. Large-size scanning was first performed to acquire the images of the whole cell and then small-size scanning was performed to acquire the images of the local areas on the cell surface. For each situation, with different stimulation times (12, 24, 48 h ), different drug concentrations (5, 10, 20 μg/mL), and different combinations of agents (cisplatin, cisplatin + Rtx, cytarabine, cytarabine + Rtx, cisplatin + cytarabine, cisplatin + cytarabine + Rtx), AFM images were obtained on 20 cells.
D. AFM Indenting
For AFM indenting, Raji cells (treated by different drug combinations in cell incubator) from the 24-well culture plates were dropped onto the poly-L-lysine-coated glass slides. The glass slides were then immediately placed in a Petri dish containing RPMI-1640 medium. After putting the Petri dish on the AFM stage, the AFM tip was moved to the cells under the guidance of optical microscopy. Before recording force curves on the cells, force curves were obtained on the bare area of the substrate to calibrate the deflection sensitivity of the probe. Then, the exact spring constant of the probe was calibrated by the thermal noise analysis [10] . The principle of calculating cellular Young's modulus by AFM indenting experiments is shown in Fig. 2(b) . AFM tip was controlled to indent the cell surface. During the indenting process, the tip first approaches and indents the cell surface. When the maximal loading force is achieved, the AFM tip retracts from the cell surface. During the approach-retract cycle, the deflection of the cantilever is detected by a beam of laser via a four-quadrant photodiode position sensitivity detector. The distance between AFM probe and substrate is acquired from the piezoelectric ceramic driver. Then, we can obtain the so-called force curves, as shown in Fig. 2(c) . The shape of force curve changes from flat to bent after AFM tip contacts the cell surface. The approach curve is used to calculate cellular Young's modulus, while the retract curve is used to measure the cellular adhesion forces [19] . By fitting the approach curve with Hertz-Sneddon model (Hertz model is used for sphere tip and Sneddon model is used for conical tip), the cellular Young's modulus is obtained [20] . Force curves were obtained at the different points of the central areas on the cell surface. All force curves were obtained at the same loading rate (40 nN/s). The maximal loading force of recording force curves was 10 nN. For each situation, with different stimulation times (12, 24, 48 h ), different drug concentrations (5, 10, 20 μg/mL), and different combinations of agents (cisplatin, cisplatin + Rtx, cytarabine, cytarabine + Rtx, cisplatin + cytarabine, cisplatin + cytarabine + Rtx), force curves were obtained on 15-20 cells and ∼20 force curves were obtained on each cell.
E. Data analysis
The surface roughness was calculated by analyzing the height images via the offline software Nanoscope Analysis (Bruker, Santa Barbara, CA, USA) [21] . The obtained surface roughness R q is the root-mean-square average of the height deviations taken from the mean image data plane
where N is the number of the points within the selected region of the image, and Z i is the current height values. Because the shape of the tip used here was conical, the cellular Young's modulus E was calculated by fitting the force curves with Sneddon-extended Hertz model
where υ is the Poisson ratio of cell (cells are often considered as incompressible materials, thus υ = 0.5), δ is the indentation depth, θ is the half-opening angle of the AFM tip, and F is the loading force. The loading force F was obtained according to the Hooke's law
where k is the spring constant of the probe and x is the deflection of the cantilever. The cantilever deflection x was directly read from the original force curve, while the indentation depth δ was computed by subtracting the cantilever deflection from the vertical movement of the probe according to the contact point visually determined in the force curve [19] - [21] . The software for extracting the Young's modulus from the force curves was programmed by us using MATLAB. A two-tailed student's t-test was applied to determine the significant difference of cellular surface roughness and Young's modulus.
III. RESULTS AND DISCUSSION
We first qualitatively investigated the influence of Rtx on the killing effects of chemotherapy drugs (cisplatin, cytarabine) by trypan blue staining and haemocytometer cell counting (see Fig. 3 ). Fig. 3(a) shows the viability of Raji cells 12 h after being treated by cisplatin and cisplatin + Rtx, respectively. In order to make the results comparable, the concentration of Rtx was unchanged (20 μg/mL) for different concentrations (1, 2, 5, 10, 20 μg/mL) of cisplatin. We observed that the addition of Rtx to cisplatin resulted in the decrease of cell viability and the influence of Rtx became more obvious as the concentration of cisplatin increased. Fig. 3(b) is the viability of Raji cells 12 h after being treated by cytarabine and cytarabine + Rtx, respectively, showing that the addition of Rtx to cytarabine also resulted in the decrease of cell viability. Then, we investigated the influence of Rtx on the combinational use of cisplatin and cytarabine. As seen in Fig. 3(c) , the addition of Rtx distinctly strengthened the killing effects of cisplatin and cytarabine. The results also showed that the Rtx's enhancing effect became weakened as the concentration of chemotherapy drugs and the stimulation time increased (e.g., when the concentration was 20 μg/ml and the stimulation time was 48 h the addition of Rtx just resulted in a little decrease of cell viability). Both cisplatin and cytarabine are commonly used chemotherapy drugs in treating B-cell lymphomas [22] , [23] . Cisplatin molecules can cross-link DNAs in the cancer cell, which ultimately triggers the cellular apoptosis. Cytarabine is an antimetabolic agent which can interfere with the synthesis of DNA, and, thus, impedes the proliferation of the cancer cell. Alas et al. [24] have shown that the addition of Rtx to cisplatin could activate the apoptosis pathway on lymphoma cell line 2F7, which resulted in the apoptosis of cisplatin-resistant cells. Here, on lymphoma Raji cell line, the addition of Rtx could both improve the killing effects of cisplatin and cytarabine. The binding of Rtx to the CD20s on the surface lymphoma cells can directly activate the apoptosis pathway of the lymphoma cells [4] , which might cooperate with the signaling pathways (such as interfering with the DNA) activated by chemotherapy drugs. This cooperation may then improve the killing effects to lymphoma cells. In 2008, studies by Vellenga et al. [22] and Martin et al. [23] have shown that the addition of Rtx to DHAP (cisplatin-cytarabin-dexamethasone) chemotherapy and ESHAP (etoposide, cytarabine, cisplatin, and methylprednisolone) chemotherapy can both significantly improve the remission rates of CD20 + lymphoma patients, clinically demonstrating the positive role of Rtx to chemotherapy drugs.
The results in Fig. 3 qualitatively showed the enhancing effect of Rtx on chemotherapy drugs (cisplatin, cytarabine) by optical microscopy. However, optical microscopy cannot reveal the nanoscale situations taking place during the actions of Rtx and chemotherapy drugs due to the limit of 200-nm spatial resolution. By AFM imaging, we visualized the changes of cellular ultramicrostructures after the stimulations of different drug combinatioins. First, the images of lymphoma Raji cells without drug stimulation were acquired, as shown in Fig. 4 . Only AFM deflections images were shown in Fig. 4 . Fig. 4 (a) and (c) shows the AFM images of the whole cells, and Fig. 4 (b) and (d) shows the images of local areas (denoted by the dashed squares) on the cell surface. We can see that the cells were plump and cellular surface was intact. Besides, the AFM images clearly showed the corrugated and rough topography of the cell surface. We know short microvilli cover the surface of lymphocytes [25] . This structure facilitates the lymphocytes to perform immune functions, such as cell adhesion [18] . The abundant microvillus on the cell surface result in the ruffled topography of the cell surface observed by AFM imaging. Fig. 5 shows the AFM images of Raji We can see that after the stimulation of cisplatin, the cell surface was not intact and distinct pores occurred on the cell surface. showed that cellular surface changed remarkably after drug stimulations and the change of stimulation conditions (the addition of Rtx, the increase of stimulation concentration, the increase of stimulation time) could result in more significantly morphological alterations on the cells (e.g., distinct particles and pores occurred on the cell surface, cellular shape became irregular, cellular nuclei were discerned). Traditional studies for investigating the anticancer effects of chemotherapy drugs or monoclonal antibodies were commonly based on the ensemble results on a large number of cells by using various biochemical methods [26] - [28] , e.g., flow cytometry, western immunoblotting, polymerase chain reaction (PCR), and proliferation/death assays. The flaw of these studies was that they cannot reveal the nanoscale situations taking place on single cells during the process of drug actions. AFM singlecell imaging can directly visualize the dynamical changes of cellular nanostructures after drug stimulation [29] , [30] , which is complementary to the traditional ensemble results. Though optical microscopy can theoretically achieve 200-nm spatial resolution. The advantage of AFM imaging is that it can yield detailed 3-D topography information of the cell surface (such as the pores and particles on the cell surface as shown in Figs. 4 and 5), which is inaccessible by optical microscopy [15] , [31] . By combining the results obtained by AFM imaging with the results obtained by traditional methods, we can then better understand the cellular physiological activities. Here, our results acquired by AFM imaging notably revealed the drug-induced morphological changes (e.g., cell membrane, cell shape, cell nucleus) on single lymphoma cells at the nanoscale, providing an intuitive understanding of the killing effects of anticancer drugs (cisplatin, cytarabine, Rtx) during the actions of single agents and combined agents.
It should be noted that AFM images (see Figs. 4 and 5) were obtained on chemically fixed Raji cells. In future, we want to directly observe the morphological changes on living Raji cells.
In this case, we should first immobilize Raji cells onto the substrate. For adherent cells, they can naturally grow and spread on the substrate [32] . While for human suspended cells (such as Raji cells), they cannot naturally adhere to the substrate, and we should use immobilization methods to trap them on the substrate, such as microfabricated pillars or microwells [12] . Imaging living cells after drug stimulation can reveal the real-time morphological changes, which is useful for us to understand the dynamics of cellular behaviors.
The roughness of cell membrane has become a potential biomarker for indicating the cell's health state [33] , [34] . Based on the AFM images obtained on the Raji cells stimulated by single agents and combined agents, the dynamical changes of cellular surface roughness were quantitatively measured. The root-mean-square roughness (R q ) of AFM height image was automatically extracted by using the AFM software Nanoscope Analysis (Bruker, Santa Barbara, CA, USA), as shown in Fig. 6 . The option "Image R q " in the software interface indicates the R q of the whole image. Here, we measured cellular surface roughness on chemically fixed cells. When performing AFM imaging on living cells, the soft and dynamic nature of cell membrane makes that the tip can easily deform the cell surface [35] which introduces artificial errors if we directly evaluate cell roughness based on the images on living cells. Hence, current studies about measuring the cellular surface roughness by AFM are commonly performed on fixed cells [33] , [34] , [36] . However, chemical fixation inevitably alters the structures of cells. Hence, if we use adequate methods to inhibit the motion of membrane (such as the grid membranes with pores) and then image the local areas on the surface of living cells, we may better understand the cellular surface roughness. Fig. 7 shows the changes of cellular surface roughness after the stimulations of single agents and combined agents. For each situation, with different stimulation times (12, 24, 48 h), different drug concentrations (5, 10, 20 μg/mL), and different combinations (Cisplatin, Cisplatin and Rtx, Cytarabine, Cytarabine and Rtx, Cisplatin and Cytarabine, Cisplatin and Cytarabine and Rtx), AFM local area images (the scanning sizes were about 4-12 μm depending on the cell size) were obtained on about 20 cells and these images were used to calculate the cellular surface roughness. Fig. 7(a) shows the contrasts of cellular surface roughness with stimulation concentration 5 μg/mL and stimulation time 12 h. For cisplatin, we observed that the addition of Rtx could make the cell surface become significantly rougher. While for cytarabine, the addition of Rtx did not cause the significant increase of cellular surface roughness. For the combination of cisplation and cytarabine, the addition of Rtx also had no significant effects on cellular surface roughness. When the stimulation time increased to 24 h [see Fig. 7(b) ], the results showed that the addition of Rtx to cisplatin and the combination cisplatin and cytarabine could both make cellular surface become distinctly rougher. When the stimulation time increased to 48 h [see Fig. 7(c) ], we got the results similar to Fig. 7(a) . Fig. 7(d)-(f) shows the changes of cellular surface roughness stimulated with 10 μg/mL agents for 12, 24, and 48 h, respectively. We can see that the addition of Rtx to cisplatin, cytarabine, and the combination cisplatin and cytarabine could all result in the rougher cellular surface when the stimulation time was less than 24 h [see Fig. 7(d) and (e) ]. When the stimulation time increased to 48 h [see Fig. 7(f) ], the addition of Rtx did not have significant effects on cytarabine. Fig. 7(g )-(i) shows the changes of cellular surface roughness stimulated with 20 μg/mL agents for 12, 24, and 48 h, respectively. When the stimulation time was 12 h [see Fig. 7(g) ], the addition of Rtx to cisplatin, cytarabine, and cisplatin and cytarabine all made the cellular surface become distinctly rougher. When the stimulation time increased to 24 [see Fig. 7(h) ] and 48 h [see Fig. 7(i) ], the enhancing effect of Rtx weakened and almost no significant effects were observed. In these cases (see Fig. 7 (h) and (i)], the roughness of each situations (single chemotherapy agents or combined with Rtx) was a relatively large value (200-300 nm) compared with the roughness in the cases where Rtx had significant enhancing effects [see Fig. 7(d) , (e), and (g)].
The results in Fig. 7(h) and (i) were consistent with the viability assay results in Fig. 3. From Fig. 3(i)-(k) , we can see that the enhancing effects of Rtx remarkably decreased when the stimulation time increased to 48 h and the concentration increased to 20 μg/mL. We also evaluated the surface roughness of Raji cells without drug stimulation (∼20 cells were measured), as shown in Table I. Table I shows the roughness values of Raji cells in three conditions (5 μg/ml, 12 h; 10 μg/ml, 24 h; 20 μg/ml, 48 h) and that from control group (without drug). We can clearly see that the surface roughness of Raji cells without drug stimulation (102.1 ± 13.5) was significantly smaller than the surface roughness of Raji cells stimulated by drugs. The chemotherapy drugs (cisplatin, cytarabine) can interact with the DNA molecules inside the cell and activate related signaling pathways (e.g., DNA damage signal, mitochondrial apoptosis), which result in the death of the cell [37] , [38] . The cytotoxic effects of cisplatin and cytarabine can cause the distinct changes of cellular surface structures (see Fig. 5 ), which then directly results in the changes of cellular surface roughness (see Fig. 7 ). The results in Fig. 7 showed the different behaviors on cellular roughness between cisplatin and cytarabine. At low concentration (5 μg/mL), the addition of Rtx had significant effects on cisplatin but not on cytarabine. At higher concentration (10, 20 μg/ml), the addition of Rtx had significant effects on both cisplatin and cytarabine, but the enhancing effect of Rtx weakened as the stimulation time [22] , [23] . The different mechanisms between cisplatin and cytarabine may then result in the various synergistic interactions after the addition of Rtx, leading to the different killing effects. Fig. 5 visually showed the changes of cellular nanostructures during the actions of chemotherapy drugs and Rtx, and here Fig. 7 quantitatively showed the changes of cellular surface roughness during the drug actions, improving our understanding of anticancer drugs on lymphoma cells from the aspect of surface roughness. The significance is that we can label-free dynamically detect the changes of cellular surface roughness to real-time monitor the drug actions, which is useful to develop novel methods for drug assessing. Studies in the past few years have shown that cellular mechanical properties are novel biomarkers for indicating the cell states [39] - [41] . For example, when a normal cell transforms into a cancer cell, it becomes softer [42] . The Young's modulus of normal and premalignant lesion tissues are significantly larger than the Young's modulus of the malignant tissues [43] . The cancer cell with higher metastatic potential has smaller Young's modulus compared with the cancer cell with less invasive potential [44] . By AFM indenting technique [42] - [44] , the changes of cellular Young's modulus during the actions of single agents and combined agents on single lymphoma cells were quantitatively measured. Fig. 8 shows the process of measuring cellular Young's modulus by AFM indenting experiments. Under the guidance of optical microscopy, the AFM tip was controlled to move to the lymphoma cell to perform indenting measurements [see Fig. 8(a) and (b) ]. Fig. 8(c) is a typical force curve (only the approach curve was shown) obtained on the substrate (a rigid material). The force curve could be divided into two portions. Before the tip contacted the substrate, the cantilever deflection of the probe was unchanged [denoted by the I in Fig. 8(c) ]. After the tip contacted the substrate, the cantilever deflection changed. Because the indentation of the substrate was tiny, the curve after the contact point was a straight line with a slope of ∼1 [denoted by the II in Fig. 8(c) ]. Fig. 8(d) is a typical force curve obtained on a Raji cell stimulated by drugs. The approach curve is used for calculating the cellular Young's modulus, while the retract curve is often used for analyzing the specific molecular binding forces [45] . Before the AFM tip contacted the cell, the cantilever deflection kept unchanged [denoted by the I in Fig. 8(d) ]. After the AFM tip contacted the cell, the tip indented the cell, which resulted in that the approach curve became bent [denoted by the II in Fig. 8(d)] . By analyzing the approach curve (the portion II after the contact point) via theoretical models, the Young's modulus of the cell was obtained. Several models are available to extract the Young's modulus from the approach curve, such as Hertz-Sneddon model, Johnson-Kendall-Roberts model, and Derjaguin-Muller-Toporov model, but in practice, due to the simpleness and effectiveness, the Hertz-Sneddon model is the most widely used model [19] . According to the contact point, the approach curve [see Fig. 8(d) ] was converted into an indentation curve [see the black curve in Fig. 8(e) ]. Then, the Hertz model was used to fit the indentation curve. Although the Hertz model is based on a number of assumptions, including homogeneity, axisymmetry, linear elastic material properties, isotropicity, infinite sample thickness, etc [30] . Studies have shown that the Hertz model is appropriate as long as the indentation is less than 10% of the cellular thickness [46] . Hence, in practice, force curves are often obtained on the central regions of the cells [47] , and the range of indentation curve for Hertz fitting is often only several hundred nanometer [48] . Fig. 8(e) shows the contrast of experimental indentation curve and Hertz fitting. We can see that the two curves were consistent with each other, indicating that the Hertz model is appropriate for describing the indenting process between AFM tip and lymphoma cell. The Young's modulus for the Hertz fitting in Fig. 8(e) was 4 kPa, indicating that the cellular Young's modulus extracted from the approach curve was 4 kPa. For one cell, about 20 force curves were obtained at the different points on the cellular central area. Studies have shown that the prolong poking (200 s) of the cell can lead to the remodeling of the cellular cytoskeleton [49] . Hence, we only recorded ∼20 force curves (much less than 200s) on each cell to avoid this effect. Each force curve was used to calculate a Young's modulus. Fig. 8(f) is the histogram of the Young's modulus of one cell. The Gaussian fitting [see Fig. 8(f) ] shows that the Young's modulus of this cell was 4.1 ± 0.7 kPa.
Based on the process of extracting cellular Young's modulus from force curves described in Fig. 8 , we then measured the changes of cellular Young's modulus after the stimulations of single drugs and combined drugs with different conditions. For each condition, with different stimulation times (12, 24, 48 h), different drug concentrations (5, 10, 20 μg/mL), and different combinations (Cisplatin, Cisplatin and Rtx, Cytarabine, Cytarabine and Rtx, Cisplatin and Cytarabine, Cisplatin and Cytarabine and Rtx), measurements were performed on 15-20 cells and ∼20 force curves were obtained on each cell. Cells (with drugs) were incubated at 37°C (5%CO 2 ) for different times (12, 24, 48 h ). After the incubation, cells were placed on the AFM sample stage for AFM indenting detection. Force curves were recorded at 25°C. Studies have shown that several factors influence the acquired Young's modulus during AFM indenting experiments, such as the substrate, the loading rate, the medium, and temperature [41] . Here, in order to make the obtained results comparable, we maintained the identical experimental conditions for all indenting experiments. Fig. 9 shows the contrasts of typical force curves recorded after the drug stimulations at one condition (5 μg/ml, 24 h). From Fig. 9(a) , we can see that the slope of the force curve (red curve) recorded on Raji cells stimulated by cisplatin and Rtx was distinctly larger than the slope of the force curve (blue curve) recorded on cells only stimulated by cisplatin. Fig. 9(b) and (c) shows the histograms of Young's modulus values calculated from the two force curves in Fig. 9(a) , respectively, showing that the cellular Young's modulus increased from 3.8 to 5.4 kPa after the addition of Rtx. For cytarabine [see Fig. 9(d)-(f) ], and cisplatin and cytarabine [see Fig. 9(g)-(i) ], we obtained the similar results; the addition of Rtx to chemotherapy drugs could make cells become stiffer. Fig. 10 shows the detailed changes of Young's modulus of Raji cells stimulated by single drugs and combined drugs with different conditions (combination, concentration, time). Fig. 10(a) shows the contrasts of cellular Young's modulus with stimulation concentration 5 μg/mL and stimulation time 12 h. We can see that for cisplatin, cytarabine, and the combination of cisplatin and cytarabine, the addition of Rtx could all make the cell surface become significantly stiffer (the cellular Young's modulus stimulated by chemotherapy drugs and Rtx was about 2.5 times larger than that stimulated only by chemotherapy drugs). Dead cells have larger Young's modulus compared with live cells [18] , [50] . After being stimulated by chemotherapy drugs and Rtx, significant changes in ultramicrostructure (e.g., pores and particles occurred on the membrane, the cytoskeleton reorganized, cell nucleus was discerned) take place, as shown in Fig. 5 . We know that the cellular structure (e.g., membrane, skeletons, nucleus) determines the cellular mechanics [51] . Thus, these changes in the cell structure could result in the changes of cellular mechanical properties. Fig. 10(a) shows that the addition of Rtx distinctly improved the killing effects of chemotherapy drugs. The results are consistent with the results of cell viability assay (see Fig. 3 ). From Fig. 3(a) -(c), we can see that the addition of Rtx to chemotherapy drugs resulted in the lower cell viability. The results in Fig. 10(a) showed that we can quantitatively characterize the enhancing effects of Rtx to chemotherapy drugs from the aspect of cell mechanics. When the stimulation time increased to 24 [see Fig. 10(b) ] and 48 h [see Fig. 10(c) ], we can observed the similar results. Comparing the results in Fig. 10(a)-(c) , we can see that as the stimulation time increased the Young's modulus of Raji cells stimulated by chemotherapy drugs also increased, and this is because that the extended stimulation time improved the killing effects of chemotherapy drugs (as shown in Fig. 3 ). When the lymphoma Raji cells were stimulated by cisplatin and cytarabine for 48 h, the addition of Rtx did not result in distinct changes on cellular Young's modulus [see Fig. 10(c)] , showing that the enhancing effect of Rtx at this condition was not significant. Fig. 10(d)-(f) shows the changes of cellular Young's modulus stimulated with 10 μg/mL agents for 12, 24, and 48 h, respectively. We can clearly see that the addition of Rtx to cisplatin, cytarabine, and the combination of cisplatin and cytarabine could all result in the significant increase of cellular Young's modulus. When the stimulation concentration of drugs increased to 20 μg/mL [see Fig. 10(g)-(i) ], we can get the same results.
For contrast, we also measured the Young's modulus of Raji cells without drug stimulations. Table I lists the Young's modulus values of Raji cells after drug stimulations in three conditions (5 μg/ml, 12 h; 10 μg/ml, 24 h; 20 μg/ml, 48 h) and that from control group (without drug). We can see that the Young's modulus of Raji cells without drug stimulations was 2.3 ± 0.7 kPa, distinctly less than the Young's modulus of cells after being treated by drugs. The results in Fig. 10 and Table I clearly showed that the stimulation of chemotherapy drugs could result in the stiffer of Raji cells, and the addition of Rtx to chemotherapy drugs could further result in the increase of cellular Young's modulus, demonstrating that cellular mechanical properties can be used to quantitatively indicate the synergistic interactions between chemotherapy drugs and targeted drugs on single cells. It should be noted that here cellular Young's modulus was acquired using conical tips whose nominal radius was ∼20 nm according to the supplier. We keep in mind that conical tips measure the mechanical properties of local areas on the cell surface, and, hence, we recorded force curves at different points on the central area of 15-20 cells to decrease the measurement errors. In recent years, researchers have used sphere tips to quantify the mechanical properties of the whole cell [44] , [52] . Despite the difference between sphere tips and conical tips, studies have shown that the results acquired via conical tips are basically consistent with that acquired via sphere tips [41] - [43] .
In recent years, both cellular surface roughness [33] , [34] , [53] , [54] and cellular mechanical properties [39] , [40] , [44] , [47] have been proved to be novel label-free biomarkers for indicating the cell states. Here, AFM imaging and indenting was applied to quantitatively characterize the dynamic changes of cellular surface roughness and cellular mechanical properties during the combinational actions of chemotherapy drugs and targeted drug on the treatment of lymphoma cells Figs. 7 and 10 , we can see that cellular mechanical properties are more sensitive to the changes of cellular states than cellular surface roughness. This to some extent may be due to the effect of cellular curvature. We know that strict roughness analysis requires the very flat surface [55] . However, when we calculate the roughness of the AFM images obtained on local areas of the cell, the cellular curvature can inevitably influence the calculating results, which may cause that the roughness is less sensitive to the cellular states than the cellular mechanical properties. How to eliminate the influence of cellular curvature is the issue that needs to be solved in the studies of AFM-based cellular surface roughness [21] . For example, we may extract the cell membranes and attach them onto flat substrate (such as mica) [56] , and then we may exactly obtain the roughness of cell membranes. Cellular physiological activities are dynamic essentially. However, traditional biochemical methods (such as fluorescence, western immunoblotting, and PCR) destroy the natural structures of cells (e.g., labeling, staining, and lysis) [26] - [28] , meaning that we cannot dynamically monitor the changes of cellular physiological parameters. Cellular surface roughness and mechanics detected by AFM are label free, and, thus, we can real-time monitor their dynamic changes on single cells, which can provide novel insights into our understanding of the dynamical cellular activities. The results in Figs. 7 and 10 showed that cellular surface roughness and cellular mechanical properties can effectively indicate the cellular states during the actions of combinational drugs. The significance is that we can develop novel methods for quantitatively evaluating the drugs at the nanoscale. For example, we can assess the drugs (single agents or combination agents) by quantitatively monitoring the morphological and mechanical changes on single cells after drug stimulations. Especially recent studies have shown that AFM can deliver drugs into single cells via the assistance of nanofluidics [57] . Compared with traditional drug assay methods, the AFM-based label-free drug assay method will have many advantages, such as inexpensive (requires only a small amount of cells and drugs), fast (several hours), and accurate (focusing on the nanoscale changes of single cells after the stimulation of controlled amount of drugs). Hence, it may play an active role in assisting drug research and development.
Currently, the challenge in lymphoma Rtx targeted therapy is to develop novel anti-CD20 antibodies with enhanced efficacies beyond that achieved with Rtx [8] , [9] . This requires us to fully understand the in vivo mechanisms of Rtx on the lymphoma patients. In the clinical practice, Rtx are often combined with chemotherapy drugs [58] , which results in that it is difficult to determine the exact contributions of Rtx to the therapeutic outcomes. Hence, investigating the synergistic interactions between Rtx and chemotherapy drugs on lymphoma cells can improve our understanding of the Rtx's real mechanisms and may potentially help us to design better anti-CD20 antibodies. In this paper, AFM was applied to visualize and quantify the nanoscale changes of cellular ultramicrostructures and cellular mechanical properties on single lymphoma cells during the combinational actions of Rtx and two commonly-used chemotherapy drugs (cisplatin and cytarabine), significantly revealing the enhancing effects of Rtx to the killing effects of chemotherapy drugs from the aspect of nanoscale cellular surface roughness and mechanical properties. The study provides a new way to quantitatively investigate the synergistic interactions between chemotherapy drugs and targeted drugs. As we are gradually entering the era of personalized medicine, exactly diagnosing the heterogeneous diseases for each patient has become more and more important. The results acquired by AFM can help us to understand the diseases from more aspects (such as nanostructure, nanomechanics), which are complementary to that acquired by traditional biochemical methods. Combining the AFM results with that acquired by other methods can, thus, help us to better understand the diseases. However, it should be noted that here the experiments were performed on lymphoma cell lines which are different from the real-world cancer cells in the patients [59] . In the future studies, we would like to apply the methods established here to investigate the combinational actions of Rtx and chemotherapy drugs directly on the cancer cells prepared from clinical lymphoma patients. For this purpose, we should first isolate the cancer cells from the prepared biopsy samples. In recent years, studies have shown that the receptor tyrosine kinase-like orphan receptor 1 (ROR1) is an adequate biomarker for recognizing the lymphoma cancer cells from the bone marrow samples of clinical lymphoma patients [10] , [60] , demonstrating the feasibility of directly probing the cancer cells from lymphoma patients. The studies directly performed on patient cancer cells will not only provide novel insights into our understanding of Rtx's real actions, but also will have impacts on diverse fields, such as drug screening, efficacy prediction, and cancer treatment.
IV. CONCLUSION
In this paper, AFM was used to quantitatively investigate the nanoscale morphological and mechanical changes on single lymphoma cells after the combinational stimulations of chemotherapy drugs and targeted drug (Rtx). AFM imaging revealed that cellular morphology changed notably (particles and pores occurred on cell surface, cellular shape became irregular, cellular nuclei were discerned) after the stimulations of chemotherapy drugs and Rtx. The quantitative analysis of AFM images showed that the addition of Rtx to chemotherapy drugs resulted in the increase of cellular surface roughness. AFM indenting measurements showed that the addition of Rtx to chemotherapy drugs could significantly result in the stiffer of cellular mechanical properties. The enhancing effects of Rtx to chemotherapy drugs weakened as the stimulation time and drug concentration increased. The results indicated the effectiveness of cellular nanostructures and mechanical properties in quantifying the enhancing effects of Rtx to chemotherapy drugs. In future studies, we plan to visualize and quantify the nanoscale cellular morphological and mechanical changes after the combinational stimulations of chemotherapy drugs and targeted drugs directly on primary cancer cells prepared from clinical lymphoma patients. These studies will be particularly useful for us to understand the real actions of targeted drugs in the clinical environments at the nanoscale, which is of evident significance for us to develop novel targeted drugs with enhanced efficacy in the coming era of personalized medicine.
